149 related articles for article (PubMed ID: 34047135)
1. [Analysis on disease burden and direct medical cost of Xueshuan Xinmaining Tablets in patients with cerebral infarction and coronary heart disease].
Hu J; Gao SQ; Wang J; Li J; Chen HW; Dai ZQ; Liao X
Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2309-2316. PubMed ID: 34047135
[TBL] [Abstract][Full Text] [Related]
2. [Explore Xueshuan Xinmaining tablet effecting on treatment outcome of coronary heart disease based on propensity score].
Li Y; Xie YM; Liu Y; Zhao W
Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4791-6. PubMed ID: 27245024
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Metabolomics Analysis of Xueshuan Xinmaining Tablet in Blood Stasis Model Rats Using UPLC-Q/TOF-MS.
Tan J; Wang C; Zhu H; Zhou B; Xiong L; Wang F; Li P; Liu J
Molecules; 2018 Jul; 23(7):. PubMed ID: 29986394
[TBL] [Abstract][Full Text] [Related]
4. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.
Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H
Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365
[TBL] [Abstract][Full Text] [Related]
5. Chemical Profiling of Xueshuan Xinmaining Tablet by HPLC and UPLC-ESI-Q-TOF/MS.
Han YX; Wang PF; Zhao M; Chen LM; Wang ZM; Liu XQ; Gao HM; Gong MX; Li H; Zhu JZ; Liu CG
Evid Based Complement Alternat Med; 2018; 2018():2781597. PubMed ID: 30420891
[TBL] [Abstract][Full Text] [Related]
6. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China].
Ma QS; Liang S; Xiao HW; Zhang SX; Zhuang GH; Zou YH; Tan HZ; Liu JC; Zhang YH; Xu AQ; Zhang L; Feng XX; Hu DS; Wang FZ; Cui FQ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):868-876. PubMed ID: 28738457
[No Abstract] [Full Text] [Related]
7. Xueshuan Xinmaining Tablet Treats Blood Stasis through Regulating the Expression of F13a1, Car1, and Tbxa2r.
Zhang X; Zhang C; Sai J; Li F; Liu J; Li Y; Wang F
Evid Based Complement Alternat Med; 2015; 2015():704390. PubMed ID: 25821496
[TBL] [Abstract][Full Text] [Related]
8. [Clinical comprehensive evaluation of Naoxintong Capsules in treatment of cerebral infarction with Qi deficiency and blood stasis syndrome and coronary heart disease angina pectoris].
Geng HJ; Xie YM; Wang ZF
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6087-6095. PubMed ID: 34951236
[TBL] [Abstract][Full Text] [Related]
9. [Network Meta-analysis of Yiqi Huoxue Chinese patent medicine for coronary heart disease with angina pectoris].
Ji ZC; Hu HY; Yang FW; Zhang LS; Jin XY; Wang HC; Pang WT; Li N; Wang KY; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2019 May; 44(9):1927-1937. PubMed ID: 31342723
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant treatment of coronary heart disease angina pectoris with Chinese patent medicine: A prospective clinical cohort study.
Liu Y; Li Z; Shen D; Song Y; Huang M; Xue X; Xie J; Jiao Z; Gao S; Xu Y; Gao S; Wang X; Xu Q; Gao S; Li C; Li L; Niu K; Yu C
Medicine (Baltimore); 2019 Aug; 98(33):e16884. PubMed ID: 31415432
[TBL] [Abstract][Full Text] [Related]
11. [Study on clinical characteristics of Danshen Chuanxiongqin Injection in treatment of cerebral infarction in real world].
Guo XC; Gao Y; Xie YM; Sun LX; Xu HY; Zhuang Y
Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(14):3307-3315. PubMed ID: 32726044
[TBL] [Abstract][Full Text] [Related]
12. The economic burden of coronary heart disease in mainland China.
Mi Y; Xue Z; Qu S; Yin Y; Huang J; Kou R; Wang X; Luo S; Li W; Tang Y
Public Health; 2023 Nov; 224():140-151. PubMed ID: 37797560
[TBL] [Abstract][Full Text] [Related]
13. [Study on medical pattern of traditional Chinese medicine and western medicine diagnosis and treatment of hypertension patients in 30 034 cases in real world].
Ma JH; Wang ZF; Xie YM; Yang W; Yang ZX; Zhuang Y; Wang YY
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3435-41. PubMed ID: 25532374
[TBL] [Abstract][Full Text] [Related]
14. The Activation of Nrf2 and Its Downstream Regulated Genes Mediates the Antioxidative Activities of Xueshuan Xinmaining Tablet in Human Umbilical Vein Endothelial Cells.
Xiong L; Xie J; Song C; Liu J; Zheng J; Liu C; Zhang X; Li P; Wang F
Evid Based Complement Alternat Med; 2015; 2015():187265. PubMed ID: 26681964
[TBL] [Abstract][Full Text] [Related]
15. [Expert consensus on clinical application of Lixuwang~® Xuesaitong Soft Capsules].
Jia M; Liang X; Fu GJ; Jin XL; Lu Y; Liao X; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5668-5674. PubMed ID: 38114160
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of traditional Chinese medicine syndrome, traditional Chinese medicine and western medicine in 84 697 patients with coronary heart disease based on big data].
Li GH; Jiang HY; Xie YM; Jiang JJ; Yang W; Zhao W; Zhuang Y; Wang YY
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3462-8. PubMed ID: 25532378
[TBL] [Abstract][Full Text] [Related]
17. [Cerebral infarction in 141 cases treated by traditional Chinese medicine and Western medicine].
Wu BQ
Zhong Xi Yi Jie He Za Zhi; 1989 Nov; 9(11):656-7, 644. PubMed ID: 2482138
[TBL] [Abstract][Full Text] [Related]
18. [Four Chinese patent medicines for regulating stomach for functional dyspepsia: a rapid health technology assessment].
Xu SM; Dai ZQ; Wu X; Li MM; Liao X
Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4778-4788. PubMed ID: 36164885
[TBL] [Abstract][Full Text] [Related]
19. [Effects of xinluotong tablet on stable coronary heart disease angina: a randomized controlled trial].
Xin L; Xu FQ; Gao R
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Sep; 31(9):1191-5. PubMed ID: 22013793
[TBL] [Abstract][Full Text] [Related]
20. Traditional Chinese Medicine in the prevention and treatment of stable angina pectoris in patients with coronary heart disease based on the theory of "phlegm and blood stasis" under guidance of evidence-based medicine: a prospective cohort study.
Chen Y; Xiao X; Xu X; Zhang Z; Deng Y
J Tradit Chin Med; 2021 Feb; 41(1):150-156. PubMed ID: 33522208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
